Stock listing

NASDAQ:SGEN Seagen Inc Stock

Follow Seagen Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SGEN

$228.74 USD

Close on Dec 13, 2023 · No longer trades

Mar 7, 2001 to last close +2,673% · monthly closes, Mar 7, 2001 – Dec 13, 2023
Lowest – highest close
$2.25 – $228.90 USDSince Mar 7, 2001 · lowest Apr 11, 2003 · highest Dec 12, 2023

Delisted NASDAQ:SGEN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SGEN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Seagen Inc on 6ix

Calls
9 calls with a replay · 9 with a transcript · latest Feb 15, 2023
Decks
1 deck · latest Mar 13, 2023

Events

CallWhenStatus
Seagen (SGEN) Q4 2022 Earnings CallWed, Feb 15, 2023 · 4:30 PM ETReplay
Seagen (SGEN) Q3 2022 Earnings CallThu, Oct 27, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q2 2022 Earnings CallThu, Jul 28, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q1 2022 Earnings CallThu, Apr 28, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q4 2021 Earnings CallWed, Feb 09, 2022 · 4:30 PM ETReplay
Seagen (SGEN) Q3 2021 Earnings CallThu, Oct 28, 2021 · 4:30 PM ETReplay
Seagen (SGEN) Q2 2021 Earnings CallThu, Jul 29, 2021 · 4:30 PM ETReplay
Seagen (SGEN) Q1 2021 Earnings CallThu, Apr 29, 2021 · 4:30 PM ETReplay
Seagen (SGEN) Q4 2020 Earnings CallThu, Feb 11, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2023)Merger or acquisition20 slidesMar 13, 2023

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alpna Seth
Other companies: Keros Therapeutics, Inc. (Director · Since at least May 1, 2023); Bio-Techne Corp (Director · Since at least Oct 26, 2017)
Director · Mar 15, 2018 – Dec 14, 2023 · Past
David R. Epstein
Other companies: AgomAb Therapeutics NV (Director · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024)
CEO, Director · Nov 10, 2023 – Dec 14, 2023 · Past
Jean Liu
Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Erasca, Inc. (Director · Since at least Jan 1, 2024)
Chief Legal Officer · Dec 14, 2023 – Dec 14, 2023 · Past
Todd Simpson
Other companies: Xencor, Inc. (Director · Since at least Mar 13, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past)
Chief Financial Officer · Apr 20, 2022 – Dec 14, 2023 · Past
Marc E. Lippman
Other companies: Ascentage Pharma Group International (Independent non-executive Director · Since at least Mar 18, 2026)
Director · May 20, 2019 – May 14, 2021 · Past
Morris Rosenberg
Other companies: Immunomedics Inc (Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past)
EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about Seagen Inc.